World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
44290
World Ranking
2079
National Ranking
1016

Overview

John R. Wunderlich is affiliated with the National Institutes of Health in the United States. Their research focuses primarily on medicine, with particular emphasis on immunology and microbiology.

Their subfields of study include oncology and immunology, reflecting a concentrated interest in cancer and immune system functions. The main topics covered in their work encompass immunotherapy and immune responses, CAR-T cell therapy research, and cancer immunotherapy and biomarkers.

Wunderlich's research outputs are published in venues such as Cancer Research. A notable publication from 2021 is titled "Abstract 1509: A signature for tumor neoantigen-reactive T-cells in fresh human lung cancers allows rapid cloning of their receptors," published in Cancer Research.

  • Ken-ichi Hanada
  • Chihao Zhao
  • Raúl Gil-Hoyos
  • Jared J. Gartner
  • Christopher A. Chow

This list represents frequent co-authors who have collaborated on related research projects, contributing to the collective body of scientific work in cancer immunotherapy and cellular therapies.

  • Cancer Research

Best Publications

  • Cancer regression in patients after transfer of genetically engineered lymphocytes

    Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes

  • Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

    Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang

  • Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

    Steven A. Rosenberg;James C. Yang;Richard M. Sherry;Udai S. Kammula

  • Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

    Eric Tran;Simon Turcotte;Alena Gros;Paul F. Robbins

  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

    Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu

  • Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    Mark E. Dudley;John R. Wunderlich;James C. Yang;Richard M. Sherry

  • Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

    Mojgan Ahmadzadeh;Laura A. Johnson;Bianca Heemskerk;John R. Wunderlich

  • Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

    Paul F. Robbins;Richard A. Morgan;Steven A. Feldman;James C. Yang

  • Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

    Laura A. Johnson;Richard A. Morgan;Mark E. Dudley;Lydie Cassard

  • Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

    Mark E. Dudley;James C. Yang;Richard Sherry;Marybeth S. Hughes

  • A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

    Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Jennifer A. Westwood;Jennifer A. Westwood;Linda L. Parker;Gang Wang;Gang Wang

  • PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

    Alena Gros;Paul F. Robbins;Xin Yao;Yong F. Li

  • Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients

    Mark E. Dudley;John R. Wunderlich;Thomas E. Shelton;Jos Even

  • Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

    Alena Gros;Maria R Parkhurst;Eric Tran;Anna Pasetto

  • A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

    Paul F. Robbins;Sadik H. Kassim;Thai Lan N. Tran;Jessica S. Crystal

  • Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells

    Sanja Stevanović;Lindsey M. Draper;Michelle M. Langhan;Tracy E. Campbell

  • Immunogenicity of somatic mutations in human gastrointestinal cancers

    Eric Tran;Mojgan Ahmadzadeh;Yong Chen Lu;Alena Gros

  • Cutting Edge: Persistence of Transferred Lymphocyte Clonotypes Correlates with Cancer Regression in Patients Receiving Cell Transfer Therapy

    Paul F. Robbins;Mark E. Dudley;John Wunderlich;Mona El-Gamil

  • Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

    Mark E. Dudley;John Wunderlich;Michael I. Nishimura;David Yu

  • A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.

    Mark E. Dudley;John R. Wunderlich;James C. Yang;Patrick Hwu

Frequent Co-Authors

Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Mark E. Dudley
Mark E. Dudley Novartis (Switzerland)
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Paul F. Robbins
Paul F. Robbins National Cancer Institute
Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
David M. Segal
David M. Segal University of California, Davis
Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Suzanne L. Topalian
Suzanne L. Topalian Johns Hopkins University
Francesco M. Marincola
Francesco M. Marincola National Institutes of Health
Richard A. Morgan
Richard A. Morgan University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many professionals transition into nursing fields, where a strong background in immunology is invaluable. Options like accelerated FNP programs provide a fast track to becoming a Family Nurse Practitioner, combining clinical expertise with immunological knowledge. You can find reputable options by researching accelerated fnp program offerings.

Non-nurses seeking entry into nursing may consider online rn programs for non nurses. These programs are designed to equip learners with foundational nursing skills quickly while allowing flexibility in completing the curriculum remotely.

If speed and accessibility are priorities, many students look for accelerated nursing programs near me. These programs focus on fast-paced coursework that can help qualified individuals earn a Bachelor of Science in Nursing (BSN) efficiently.

For careers with shorter training periods, easiest lpn programs to get into can be a practical starting point. Licensed Practical Nurse (LPN) programs offer hands-on training and strong employment prospects, often serving as a stepping stone to further advanced nursing degrees.

Best Scientists Citing John R. Wunderlich

Trending Scientists

Recently Published Articles